Skip to content

Competence Ability Study in People With Schizophrenia

Competence Ability Study in People With Schizophrenia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01045629
Acronym
CompSchizo
Enrollment
90
Registered
2010-01-11
Start date
2009-10-31
Completion date
2010-06-30
Last updated
2010-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Competence, Schizophrenia

Keywords

schizophrenia, PANSS

Brief summary

The goal of this research is to understand whether schizophrenic patients are capable of comprehending clinical trial consent form or influenced by disease, also after intensified educational illustration for understanding of consent form, their comprehension increased or not, in order to protect patient's right.

Detailed description

The goal of this research is to understand whether schizophrenic patients are capable of comprehending clinical trial consent form or influenced by disease, also after intensified educational illustration for understanding of consent form, their comprehension will increase or not, in order to protect patient's right. First week, inform the patient a putative goal and method of clinical trial medicine research, then using Macarthur comprehension evaluation tool-clinical research Ed., evaluate the understanding of all patients for this putative clinical trial research consent form. For experimental group schizophrenic patients, using PANSS score evaluate seriousness of their symptom. 2 weeks later, randomly stratify schizophrenic patients into 2 groups, one give educational intervention for consent form, the other does not, then evaluate again with Macarthur comprehension evaluation tool-clinical research Ed. and PANSS score.

Interventions

OTHERConsent form education

Randomly stratified schizophrenic patients group, some receive consent form education, the others not.

Sponsors

Taichung Veterans General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Experimental group 1. Age between 20 to 60, all genders. 2. Psychiatry doctor diagnosed who met DSMIV-TR criteria schizophrenia. 3. Participants require adequate ability to have a interview about 60-70min (include PANSS and Macarthur comprehension evaluation tool-clinical research Ed.). Control group 1. Age between 20 to 60, all genders. 2. Psychiatry doctor diagnosed who exclude DSMIV-TR axis. I and II. 3. Participants require adequate ability to have a interview about 30min (include PANSS and Macarthur comprehension evaluation tool-clinical research Ed.).

Exclusion criteria

Experimental group and control group Participants have no adequate ability to have a interview about 60-70min (include PANSS and Macarthur comprehension evaluation tool-clinical research Ed.).

Countries

Taiwan

Contacts

Primary ContactTsuo-Hung Lan, MD., PhD.
tosafish@hotmail.com04-23592525
Backup ContactYuan-Feng Chang, MD.
04-23592525

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026